PDGFRB rearrangements
About
Gene context: PDGFRB
Biomarker Type: Rearrangement
Present: True
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | PDGFRB rearrangements | Myelodysplastic Syndromes | Imatinib | |
| EMA (1) | PDGFRB rearrangements | Myeloproliferative Neoplasm | Imatinib |